Cellectar Biosciences, Inc.
CLRB
$2.37
-$0.05-1.87%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 33.99M | 8.35M | 13.20M | 12.55M | 11.04M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 883.70K | 920.00K | 842.40K | 1.07M | 1.58M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 34.88M | 9.27M | 14.04M | 13.62M | 12.62M |
|
|
|||||
| Total Current Assets | 34.88M | 9.27M | 14.04M | 13.62M | 12.62M |
| Net Property, Plant & Equipment | 1.74M | 1.82M | 910.10K | 976.10K | 1.05M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 23.60K | 29.80K | 29.80K | 29.80K | 29.80K |
| Total Assets | 36.64M | 11.12M | 14.98M | 14.63M | 13.70M |
|
|
|||||
| Total Accounts Payable | 5.22M | 4.72M | 1.44M | 4.01M | 4.68M |
| Total Accrued Expenses | -- | -- | 2.48M | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.00K | -- | 100.20K | 96.00K | 92.00K |
| Total Finance Division Other Current Liabilities | 17.00K | 149.00K | 725.00K | 801.70K | 1.10M |
| Total Other Current Liabilities | 17.00K | 149.00K | 725.00K | 801.70K | 1.10M |
| Total Current Liabilities | 5.24M | 4.87M | 4.75M | 4.91M | 5.87M |
|
|
|||||
| Total Current Liabilities | 5.24M | 4.87M | 4.75M | 4.91M | 5.87M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.53M | 1.53M | 309.40K | 335.90K | 361.50K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 6.77M | 6.40M | 5.06M | 5.25M | 6.23M |
|
|
|||||
| Common Stock & APIC | 311.59M | 277.60M | 277.15M | 271.31M | 264.96M |
| Retained Earnings | -281.72M | -274.79M | -269.13M | -263.84M | -259.39M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 29.87M | 2.81M | 8.02M | 7.48M | 5.56M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | 1.90M | 1.90M | 1.90M | 1.90M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | 1.90M | 1.90M | 1.90M | 1.90M |
|
|
|||||
| Total Common Equity | 29.87M | 2.81M | 8.02M | 7.48M | 5.56M |
| Total Preferred Equity | -- | 1.90M | 1.90M | 1.90M | 1.90M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 29.87M | 4.72M | 9.92M | 9.38M | 7.47M |
|
|
|||||